Ictero Medical aims to give patients with gallstone disease the benefits of invasive surgery without the associated risks. It just raised $6 million in series A financing in a round led by Connecticut-based MedTex Ventures, Austin-based S3 Ventures and an undisclosed strategic investor. "Ictero is at the forefront of pioneering cryotherapy for gallstone disease, and S3 Ventures is excited about the potential for Ictero’s novel solution to rapidly bring an impactful outcome to patients," stated Kim Rodriguez, venture partner at S3.